VNDA Latest Quarter’s Earnings
Announce Date10/28/2026
EPS Actual (USD)-0.37
Revenue Actual (USD)69.81M
This page offers detailed Vanda Pharmaceuticals Inc earnings data including the latest Vanda Pharmaceuticals Inc earnings report, the upcoming Vanda Pharmaceuticals Inc earnings date, historical data and Vanda Pharmaceuticals Inc earnings call news.
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 10/28/2026 | 09/2026 | -0.37/-0.68 | 69.81M/69.20M | 45.29% | 0.89% |
| 8/6/2026 | 06/2026 | -1.04/-0.59 | 50.53M/61.92M | -76.67% | -18.40% |
| 5/6/2026 | 03/2026 | -0.82/-0.69 | 51.72M/54.98M | -18.72% | -5.93% |
| 2/11/2026 | 12/2025 | -2.39/-1.32 | 57.22M/59.27M | -80.30% | -3.47% |
| 10/29/2025 | 09/2025 | -0.38/-0.45 | 56.26M/58.73M | 15.69% | -4.21% |
| 7/31/2025 | 06/2025 | -0.46/-0.36 | 52.59M/54.60M | -29.30% | -3.68% |
| 5/7/2025 | 03/2025 | -0.50/-0.60 | 50.04M/45.13M | 15.54% | 10.87% |
| 2/13/2025 | 12/2024 | -0.08/-0.11 | 53.19M/52.25M | 21.03% | 1.79% |
Vanda Pharmaceuticals (VNDA) Q3 2026 Earnings Call: Revenue Up 24%, Expenses Decline